Test Price
2,800 AED✅ Home Collection Available
ZCCHC12 Gene Non-Syndromic Intellectual Disability Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain. VIP Mobile Phlebotomy available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a qualified genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (copy of Emirates ID & policy required).
Test Overview & Methodology
The ZCCHC12 gene NGS test detects pathogenic variants linked to non-syndromic intellectual disability (NSID) with single-nucleotide resolution. This analysis is used to confirm genetic diagnosis and guide clinical management for individuals with non-syndromic developmental delay.
| Feature | Our Test (NGS Full Gene Sequencing) | Closest Alternative (Chromosomal Microarray) |
|---|---|---|
| Precision | Single-nucleotide variant detection; >99.9% analytical sensitivity | Detects large deletions/duplications; misses point mutations |
| Methodology | Next-Generation Sequencing (NGS) with Sanger confirmation | Array-CGH / SNP microarray |
| Turnaround Time | 3–4 Weeks from sample receipt | 4–6 Weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA ID: 9294403) advises: “I understand the emotional weight a developmental delay brings to a family. This genetic test sheds light on the molecular aetiology of your child’s condition, but it is not a standalone verdict. Please remember that a variant must be correlated with a thorough neurological and developmental assessment before any clinical conclusion is drawn.”
Advisory Notes
⚠️ Medication Warning
Do not discontinue any prescribed medication, including antiepileptics or behavioural therapies, without explicit instruction from your treating physician. Abrupt withdrawal may precipitate serious medical events.
Exclusion Criteria & Emergency Red Flags
Medical Red Flags
- Active febrile illness (postpone sample collection until afebrile for 48 hours).
- Known current use of anticoagulants other than aspirin (contact phlebotomist for special preparation).
- Inability to provide informed consent from a legal guardian.
- Seek immediate medical attention (ER) if: new-onset seizures, sudden loss of speech or motor skills, or signs of self-harm.
Patient FAQ & Clinical Guidance
1. What does the ZCCHC12 gene test actually detect, and how reliable is it?
This test identifies single-nucleotide variants and small insertions/deletions in the entire coding region of the ZCCHC12 gene with >99.9% analytical sensitivity and specificity, enabling precise molecular diagnosis of non-syndromic intellectual disability.
2. Is home sample collection safe and accepted by DHA-licensed labs?
Our hospital-grade home collection complies with UAE Personal Data Protection Law (PDPL) and Federal Law No. 2 of 2019 on Health ICT, using cold-chain validated kits and DHA-licensed phlebotomists to preserve DNA integrity from doorstep to lab.
3. How should I prepare my child for the test, and what if the result is negative?
No fasting is required; simply provide a brief clinical history and a three-generation family pedigree chart during the pre-genetic counselling session, and note that a negative result does not exclude all genetic causes.
UAE Regulatory & Data Privacy Adherence
This service is licensed by the Dubai Health Authority (DHA) under facility license number 1143. All data protection procedures comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent processes adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | ZCCHC12 Gene Non-Syndromic Intellectual Disability Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3-4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3-5 mL) or Saliva (2 mL) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | F79 (Unspecified intellectual disability) |
| LOINC Code | 81247-9 (Gene mutations detected in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians